Parkinson's Disease

Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Marketwatch
Denali Therapeutics
Biogen
Parkinson's Disease
Flag link:
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
AbbVie
Alzheimer's disease
Parkinson's Disease
Voyager Therapeutics
Flag link:
One-and-done gene therapy wipes out Parkinson's symptoms in mouse models
One-and-done gene therapy wipes out Parkinson's symptoms in mouse models
Fierce Biotech
USCD
Parkinson's Disease
gene therapy
Flag link:
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes
Xconomy
Sunovion
FDA
Parkinson's Disease
Kynmobi
Flag link:
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
Flag link:
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
Flag link:
Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure
Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure
Endpoints
Novartis
ResTORbio
M&A
Parkinson's Disease
Adicet Bio
Flag link:
FDA Approves Neurocrine Biosciences' Parkinson's Drug
FDA Approves Neurocrine Biosciences' Parkinson's Drug
Motley Fool
Neurocrine
FDA
Ongentys
Parkinson's Disease
Flag link:
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Biopharma Dive
Neurocrine
Parkinson's Disease
drug launches
COVID-19
pandemic
Flag link:
Cerevance Nabs $45 Million in Funding to Support CNS Disease Research
Cerevance Nabs $45 Million in Funding to Support CNS Disease Research
BioSpace
Cerevance
CNS
Alzheimer's disease
Parkinson's Disease
Flag link:
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic
Xconomy
Aspen Neuro
Parkinson's Disease
cell therapy
Flag link:
Lundbeck adds a Parkinson's flop to its list of setbacks, writing off a $1.1 billion deal on mid-stage failure
Lundbeck adds a Parkinson's flop to its list of setbacks, writing off a $1.1 billion deal on mid-stage failure
Endpoints
Lundbeck
R&D
Parkinson's Disease
foliglurax
Flag link:
Swiss bio Addex halts Parkinson's test as trial delays tick up on COVID-19 disruption
Swiss bio Addex halts Parkinson's test as trial delays tick up on COVID-19 disruption
Fierce Biotech
Addex Therapeutics
Parkinson's Disease
dipraglurant
COVID-19
Flag link:
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
Flag link:
New Molecule Has the Potential of Stopping or Slowing Parkinson’s
New Molecule Has the Potential of Stopping or Slowing Parkinson’s
BioSpace
Parkinson's Disease
BT13
Flag link:
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Flag link:
Gut link to Parkinson's sparks talk of probiotic treatment strategy
Gut link to Parkinson's sparks talk of probiotic treatment strategy
Fierce Biotech
Parkinson's Disease
probiotics
microbiome
Flag link:
How Novartis' cancer drug Tasigna restores critical dopamine that's lost to Parkinson's disease
How Novartis' cancer drug Tasigna restores critical dopamine that's lost to Parkinson's disease
Fierce Biotech
Tasigna
Novartis
Parkinson's Disease
Flag link:
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
Xconomy
Aspen Neuro
Parkinson's Disease
stem cell therapy
Flag link:
RightEye Has “Breakthrough” in Its Vision for Parkinson’s Test
RightEye Has “Breakthrough” in Its Vision for Parkinson’s Test
Medical Devices and Diagnostics Industry
RightEye
RightEye Vision System
diagnostics
Parkinson's Disease
Flag link:

Pages